CD274 and neoplasm: Even though the optimal sequencing of radiotherapy and immunotherapy remains unknown with conflicting preclinical data and needs to be determined through clinical trials, this case report suggests that patients who initially lack PD-L1 expression in the tumor may benefit from radiotherapy first to induce PD-L1 expression in the tumor followed by immunotherapy for a better response.